267 related articles for article (PubMed ID: 28085101)
1. Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.
Qi C; Han T; Tang H; Huang K; Min J; Li J; Ding X; Xu Z
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085101
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
3. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways.
Chen J; Lan T; Zhang W; Dong L; Kang N; Fu M; Liu B; Liu K; Zhang C; Hou J; Zhan Q
Arch Biochem Biophys; 2015 Jun; 575():38-45. PubMed ID: 25843419
[TBL] [Abstract][Full Text] [Related]
5. STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.
Timme S; Ihde S; Fichter CD; Waehle V; Bogatyreva L; Atanasov K; Kohler I; Schöpflin A; Geddert H; Faller G; Klimstra D; Tang L; Reinheckel T; Hauschke D; Busch H; Boerries M; Werner M; Lassmann S
Oncogene; 2014 Jun; 33(25):3256-66. PubMed ID: 23912451
[TBL] [Abstract][Full Text] [Related]
6. [Overexpression of p-Stat3 and Mcl-1, and their correlation with differentiation and apoptotic resistance in esophageal squamous cell carcinoma].
Huo YQ; Ruan X; DU XL; Shang L; Cai Y; Xu X; Wang MR; Zhang Y; Fu SB
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):579-84. PubMed ID: 24314214
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
[TBL] [Abstract][Full Text] [Related]
10. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
Cao Y; Yin X; Jia Y; Liu B; Wu S; Shang M
Int J Mol Med; 2018 Sep; 42(3):1569-1576. PubMed ID: 29901084
[TBL] [Abstract][Full Text] [Related]
11. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
[TBL] [Abstract][Full Text] [Related]
12. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
13. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
[TBL] [Abstract][Full Text] [Related]
14. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling.
Feng Y; Ke C; Tang Q; Dong H; Zheng X; Lin W; Ke J; Huang J; Yeung SC; Zhang H
Cell Death Dis; 2014 Feb; 5(2):e1088. PubMed ID: 24577086
[TBL] [Abstract][Full Text] [Related]
15. The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma.
Zhang Y; Molavi O; Su M; Lai R
BMC Cancer; 2014 Oct; 14():791. PubMed ID: 25355139
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells.
Li W; Zheng J; Deng J; You Y; Wu H; Li N; Lu J; Zhou Y
Gastroenterology; 2014 Jun; 146(7):1714-26.e5. PubMed ID: 24631494
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.
Tian X; Ma P; Sui CG; Meng FD; Li Y; Fu LY; Jiang T; Wang Y; Jiang YH
FEBS J; 2014 Jun; 281(12):2805-19. PubMed ID: 24754231
[TBL] [Abstract][Full Text] [Related]
18. Expression of activated signal transducer and activator of transcription-3 as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma.
Huang C; Wang L; Yang X; Lai L; Chen D; Duan C
World J Surg Oncol; 2015 Nov; 13():314. PubMed ID: 26553224
[TBL] [Abstract][Full Text] [Related]
19. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
[TBL] [Abstract][Full Text] [Related]
20. G6PD downregulation triggered growth inhibition and induced apoptosis by regulating STAT3 signaling pathway in esophageal squamous cell carcinoma.
Wang X; Liu H; Zhang X; Li X; Gu H; Zhang H; Fan R
Tumour Biol; 2016 Jan; 37(1):781-9. PubMed ID: 26250461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
